Search
Iovance Biotherapeutics Inc
IOVAAdd to Watchlist
3.910USD
-0.020-0.51%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.75BMarket Cap
LossP/E TTM
Iovance Biotherapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Iovance Biotherapeutics Inc is 6.49, ranking 330 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.24, which is -67.86% below the recent high of -1.36 and -118.43% above the recent low of -9.25.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
